Novel form of miR-29b suppresses bleomycin-induced pulmonary fibrosis.
MicroRNA 29b (miR-29b) replacement therapy is effective for suppressing fibrosis in a mouse model. However, to develop clinical applications for miRNA mimics, the side effects of nucleic acid drugs have to be addressed. In this study, we focused on miRNA mimics in order to develop therapies for idio...
Main Authors: | Yuko Yamada, Masakatsu Takanashi, Katsuko Sudo, Shinobu Ueda, Shin-Ichiro Ohno, Masahiko Kuroda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5325218?pdf=render |
Similar Items
-
Novel Types of Small RNA Exhibit Sequence- and Target-dependent Angiogenesis Suppression Without Activation of Toll-like Receptor 3 in an Age-related Macular Degeneration (AMD) Mouse Model
by: Masakatsu Takanashi, et al.
Published: (2015-01-01) -
The role of miR-29 in pulmonary fibrosis
by: Cushing, Leah
Published: (2015) -
Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice
by: Koichiro Tsujimaru, et al.
Published: (2020-12-01) -
Acerola exosome-like nanovesicles to systemically deliver nucleic acid medicine via oral administration
by: Tomohiro Umezu, et al.
Published: (2021-06-01) -
Cisplatin induces differentiation in teratomas derived from pluripotent stem cells
by: Atsushi Kurata, et al.
Published: (2021-12-01)